Tracking the FDA advisory panel meeting on the Pfizer/BioNTech Covid-19 vaccine
A panel of outside experts is meeting Thursday to consider whether the Food and Drug Administration ought to give an emergency use authorization to the Covid-19 vaccine being developed by Pfizer and BioNTech, a vaccine that appeared to be highly efficacious in a Phase 3 clinical trial.
Earlier this week, the United Kingdom started using the vaccine, which is currently known by the working name BNT162b2. On Wednesday, Canada’s drug regulator announced it had approved emergency use of the vaccine.
